Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr Acquires Nordette From King

This article was originally published in The Pink Sheet Daily

Executive Summary

Duramed will pay approximately $12 mil. for the oral contraceptive, including exclusive manufacturing and marketing rights for the United States. Nordette is the second women's health product Barr has acquired from King.
Advertisement

Related Content

King Restatement Will Boost 2004 Revenue, Income But Hurt Prior Year Results
King Restatement Will Boost 2004 Revenue, Income But Hurt Prior Year Results

Topics

Advertisement
UsernamePublicRestriction

Register

PS058474

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel